• Home
  • News
  • Portfolio News
  • Xylyx Bio Announces Global Expansion, Adds 9 International Distributors to Meet Growing Demand

Xylyx Bio Announces Global Expansion, Adds 9 International Distributors to Meet Growing Demand

29May

Xylyx Bio Announces Global Expansion, Adds 9 International Distributors to Meet Growing Demand

Portfolio News
Xylyx Bio, a pioneer in physiomimetic cell culture, today announced that it is expanding globally to meet growing international demand for its physiologic cell culture products. Read more >>

Share this post

Related Posts

20May

Michael Bayer: ‘CFOs Are Storytellers’

Michael Bayer, CFO of Wasabi Technologies, asked this rhetorical question in response to CFO’s inquiry about the business outlook for... read more
16Oct

5 minutes with … David Friend, CEO of Wasabi

The seventh company serial entrepreneur David Friend founded across his 40-year career, Wasabi Technologies Inc., just scored what he called... read more
20May

Aramco Venture Arm Investing in U.S. Startup Wasabi

The venture capital arm of Saudi Arabia’s state-owned energy producer Aramco is investing in Boston-area cloud-storage startup Wasabi Technologies. One... read more
04Dec

Man Visually Impaired for 17 Years Sees Girlfriend for the First Time and Proposes to Her

Brittney Reed and her boyfriend Hunter Tribe looking into each other’s eyes while he is wearing eSight glasses. Tribe has... read more
20Mar

The World’s Most Innovative Companies of 2024

Candidly on the list. Read more >> read more
20Oct

See which startups are in Lafayette’s 2021 Get Started Medical Pitch Competition

Seven innovative medical startups are vying for $40,000 in cash prizes at this year's Get Started Medical Pitch Competition, which... read more
02Jun

The delivery of sight

Tina Leonard's new eSight electronic glasses came in the mail last week, and for the first time in five years,... read more
30Sep

Boston cloud startup raises big round to take on Amazon and Google

Boston entrepreneur David Friend has cofounded a half-dozen startups over the past 40 years, but he has never had such... read more
16Sep

RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial

RevBio, Inc., announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom... read more
13Dec

Boehringer Ingelheim highlights progress of immuno-oncology collaborations

In the last year, the firm has worked with the University of California at Los Angeles to develop a promising... read more